Topic: Precision Oncology – the road ahead from “vaguely right” to “precisely right” (9:00am – 10:00am) Wolfgang Hackl is Founder and CEO of OncoGenomX Inc, a Swiss company specialized in AI/CI-based digital solutions for cancer doctors. Prior to his role at OncoGenomX, Wolfgang was responsible for strategic planning at the Novartis Institutes of Biomedical Research. Wolfgang worked over 20 years in the drug development industry, at Pharmacia and Novartis, where he held several lead positions in Oncology R&D. He holds a Medical Degree from the University of Innsbruck/Austria and an ECPM-Degree in Pharmaceutical Medicine. Trained as translational oncologist he contributed directly to pharmaceutical and scientific progress to the field of precision oncology at leading companies worldwide.